AceDoPC, a structured phospholipid to target the brain with docosahexaenoic acid
Open Access
- 18 December 2015
- journal article
- research article
- Published by EDP Sciences in OCL
- Vol. 23 (1) , D102
Abstract
AceDoPC® is a structured phospholipid or acetyl-LysoPC-DHA made to prevent docosahexaenoic acyl migrating from the sn-2 to sn-1 position of the phospholipid, however keeping the main physical-chemical properties of LysoPC-DHA. As previously shown for LysoPC-DHA, AceDoPC® allows DHA crossing a re-constituted blood-brain barrier with higher efficiency than non-esterified DHA or PC-DHA. When injected to blood of rats, AceDoPC® is processed within the brain to deliver DHA to phosphatidyl-choline and -ethanolamine. When injected to rats following the induction of an ischemic stroke, AceDoPC® prevents the extension of brain lesions more efficiently than DHA. Overall, these properties make AceDoPC® a promising phospholipid carrier of DHA to the brain. AceDoPC® est un phospholipide structuré correspondant à l’acétyl-LysoPC-DHA conçu pour empêcher la migration du radical docosahexaénoyle de sa position sn-2 à la position sn-1 du phospholipide, tout en gardant les principales propriétés physico-chimiques de la LysoPC-DHA. Comme montré précédemment avec la LysoPC-DHA, AceDoPC® permet au DHA de traverser une barrière hémato-encéphalique reconstituée plus efficacement que le DHA non-estérifié et que PC-DHA. Lorsqu’il est injecté dans la circulation des rats, AceDoPC® est métabolisé au sein du cerveau en apportant le DHA aux phosphatidyl-choline et -éthanolamine. Injecté à des rats ayant subi un accident vasculaire cérébral ischémique, AceDoPC® prévient l’extension des lésions cérébrales plus efficacement que le DHA. Globalement, ces propriétés font d’AceDoPC® un transporteur de DHA phospholipidique prometteur.Keywords
This publication has 14 references indexed in Scilit:
- Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured PhospholipidMolecular Neurobiology, 2015
- Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acidNature, 2014
- Brain-Targeting Form of Docosahexaenoic Acid for Experimental Stroke Treatment: MRI Evaluation and Anti-Oxidant ImpactCurrent Neurovascular Research, 2011
- Robust Docosahexaenoic Acid–Mediated Neuroprotection in a Rat Model of Transient, Focal Cerebral IschemiaStroke, 2009
- Regulation of brain polyunsaturated fatty acid uptake and turnoverProstaglandins, Leukotrienes and Essential Fatty Acids, 2008
- Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adultsReproduction Nutrition Development, 2005
- Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout lifeReproduction Nutrition Development, 2004
- Characterization of plasma unsaturated lysophosphatidylcholines in human and ratBiochemical Journal, 1999
- Synthesis of acetyl, docosahexaenoyl‐glycerophosphocholine and its characterization using nuclear magnetic resonanceLipids, 1999
- Unsaturated Fatty Acids Esterified in 2‐Acyl‐1‐Lysophosphatidylcholine Bound to Albumin Are More Efficiently Taken up by the Young Rat Brain than the Unesterified FormJournal of Neurochemistry, 1992